Vireo Growth Completes Acquisition of Fluent

It significantly expands the company's footprint in Florida.

Close-up of dried cannabis buds in a clear container with currency visible in background
HighGradeRoots/iStock

Vireo Growth said it has completed its previously announced acquisition of Fluent.

The deal expands Vireo’s presence in Florida, combining complementary retail and cultivation operations in one of the country’s largest medical cannabis markets, while also adding Fluent’s Buffalo, New York operations.

The acquisition adds 33 dispensaries and approximately 117,000 square feet of cultivation and production capacity to Vireo's portfolio. It expands Vireo’s current presence in Florida with its Green Dragon dispensaries to approximately 74 operational dispensaries and approximately 317,000 square feet of operational cultivation and manufacturing capacity.

“With the completion of our acquisition of Fluent, we are adding an established operator that meaningfully strengthens our position in Florida,” said Vireo CEO John Mazarakis in a statement. “Florida is an important market for Vireo. We have already seen progress in operating efficiencies based on Fluent’s implementation of an operating budget adopted by its board to streamline operations and optimize performance, and we believe bringing these businesses together gives us greater scale, a broader operating base and meaningful opportunities to continue to improve performance across the combined platform. We are excited to welcome the Fluent team to Vireo and get to work building on the foundation they have established.”

Following the completion of the transaction, Fluent’s operating entities in New York and Texas will be sold in two separate transactions. Etain, Fluent’s operating entity in New York, will be sold to a third-party operator. Immediately prior to that sale, Etain, will assign its Buffalo, New York operations, including the real property lease for its cultivation facility in Buffalo, New York, to Ace Heritage, a Vireo-affiliated entity.

Cansortium Texas, Fluent’s operating entity in Texas, will be sold to Legacy Therapeutics, pursuant to a purchase agreement that was entered into on May 1, 2026.

More in Distribution